APA

Doi T., Yoh K., Shitara K., Takahashi H., Ueno M., Kobayashi S., Morimoto M., Okusaka T., Ueno H., Morizane C., Okano N., Nagashima F. & Furuse J. (20200220). First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. : Investigational new drugs.

Chicago

Doi Toshihiko, Yoh Kiyotaka, Shitara Kohei, Takahashi Hideaki, Ueno Makoto, Kobayashi Satoshi, Morimoto Manabu, Okusaka Takuji, Ueno Hideki, Morizane Chigusa, Okano Naohiro, Nagashima Fumio and Furuse Junji. 20200220. First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. : Investigational new drugs.

Harvard

Doi T., Yoh K., Shitara K., Takahashi H., Ueno M., Kobayashi S., Morimoto M., Okusaka T., Ueno H., Morizane C., Okano N., Nagashima F. and Furuse J. (20200220). First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. : Investigational new drugs.

MLA

Doi Toshihiko, Yoh Kiyotaka, Shitara Kohei, Takahashi Hideaki, Ueno Makoto, Kobayashi Satoshi, Morimoto Manabu, Okusaka Takuji, Ueno Hideki, Morizane Chigusa, Okano Naohiro, Nagashima Fumio and Furuse Junji. First-in-human phase 1 study of novel dUTPase inhibitor TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. : Investigational new drugs. 20200220.